{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:56:21Z","timestamp":1790704581580,"version":"4.1.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2019,9,16]],"date-time":"2019-09-16T00:00:00Z","timestamp":1568592000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,9,16]],"date-time":"2019-09-16T00:00:00Z","timestamp":1568592000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Cardiol Rep"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s11886-019-1206-9","type":"journal-article","created":{"date-parts":[[2019,9,16]],"date-time":"2019-09-16T06:02:51Z","timestamp":1568613771000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Cell Cycle\u2013Mediated Cardiac Regeneration in the Mouse Heart"],"prefix":"10.1007","volume":"21","author":[{"given":"Arash","family":"Eghbali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Austin","family":"Dukes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Toischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd","family":"Hasenfuss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loren J.","family":"Field","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,16]]},"reference":[{"issue":"24","key":"1206_CR1","doi-asserted-by":"publisher","first-page":"8850","DOI":"10.1073\/pnas.1408233111","volume":"111","author":"SR Ali","year":"2014","unstructured":"Ali SR, Hippenmeyer S, Saadat LV, Luo L, Weissman IL, Ardehali R. Existing cardiomyocytes generate cardiomyocytes at a low rate after birth in mice. Proc Natl Acad Sci U S A. 2014;111(24):8850\u20135. \n                      https:\/\/doi.org\/10.1073\/pnas.1408233111\n                      \n                    .","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7432","key":"1206_CR2","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/nature11682","volume":"493","author":"SE Senyo","year":"2013","unstructured":"Senyo SE, Steinhauser ML, Pizzimenti CL, Yang VK, Cai L, Wang M, et al. Mammalian heart renewal by pre-existing cardiomyocytes. Nature. 2013;493(7432):433\u20136. \n                      https:\/\/doi.org\/10.1038\/nature11682\n                      \n                    .","journal-title":"Nature."},{"issue":"7","key":"1206_CR3","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1161\/CIRCULATIONAHA.117.029343","volume":"136","author":"T Eschenhagen","year":"2017","unstructured":". Eschenhagen T, Bolli R, Braun T, Field LJ, Fleischmann BK, Frisen J, et al. Cardiomyocyte regeneration: a consensus statement. Circulation. 2017;136(7):680\u20136. \n                      https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.117.029343\n                      \n                     This consensus statement delineates the lack of critical data supporting a direct cardiomyogenic role for purported cardiac resident stem cells, and thus underscores the need to develop alternative strategies for promoting myocardial regeneration.","journal-title":"Circulation"},{"issue":"23","key":"1206_CR4","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1093\/eurheartj\/ehw113","volume":"37","author":"R Madonna","year":"2016","unstructured":"Madonna R, Van Laake LW, Davidson SM, Engel FB, Hausenloy DJ, Lecour S, et al. Position Paper of the European Society of Cardiology Working Group Cellular Biology of the Heart: cell-based therapies for myocardial repair and regeneration in ischemic heart disease and heart failure. Eur Heart J. 2016;37(23):1789\u201398. \n                      https:\/\/doi.org\/10.1093\/eurheartj\/ehw113\n                      \n                    .","journal-title":"Eur Heart J"},{"issue":"1 Pt 2","key":"1206_CR5","first-page":"H220","volume":"272","author":"MH Soonpaa","year":"1997","unstructured":"Soonpaa MH, Field LJ. Assessment of cardiomyocyte DNA synthesis in normal and injured adult mouse hearts. Am J Phys. 1997;272(1 Pt 2):H220\u20136.","journal-title":"Am J Phys"},{"issue":"1","key":"1206_CR6","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1161\/01.RES.83.1.15","volume":"83","author":"MH Soonpaa","year":"1998","unstructured":"Soonpaa MH, Field LJ. Survey of studies examining mammalian cardiomyocyte DNA synthesis. Circ Res. 1998;83(1):15\u201326.","journal-title":"Circ Res"},{"issue":"5923","key":"1206_CR7","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1126\/science.1164680","volume":"324","author":"O Bergmann","year":"2009","unstructured":"Bergmann O, Bhardwaj RD, Bernard S, Zdunek S, Barnabe-Heider F, Walsh S, et al. Evidence for cardiomyocyte renewal in humans. Science. 2009;324(5923):98\u2013102. \n                      https:\/\/doi.org\/10.1126\/science.1164680\n                      \n                    .","journal-title":"Science."},{"issue":"7","key":"1206_CR8","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1016\/j.cell.2015.05.026","volume":"161","author":"O Bergmann","year":"2015","unstructured":"Bergmann O, Zdunek S, Felker A, Salehpour M, Alkass K, Bernard S, et al. Dynamics of cell generation and turnover in the human heart. Cell. 2015;161(7):1566\u201375. \n                      https:\/\/doi.org\/10.1016\/j.cell.2015.05.026\n                      \n                    .","journal-title":"Cell."},{"issue":"1","key":"1206_CR9","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1152\/physrev.1999.79.1.215","volume":"79","author":"B Swynghedauw","year":"1999","unstructured":"Swynghedauw B. Molecular mechanisms of myocardial remodeling. Physiol Rev. 1999;79(1):215\u201362.","journal-title":"Physiol Rev"},{"issue":"10","key":"1206_CR10","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1161\/01.RES.0000020201.44772.67","volume":"90","author":"KB Pasumarthi","year":"2002","unstructured":"Pasumarthi KB, Field LJ. Cardiomyocyte cell cycle regulation. Circ Res. 2002;90(10):1044\u201354.","journal-title":"Circ Res"},{"issue":"4843","key":"1206_CR11","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1126\/science.2964082","volume":"239","author":"LJ Field","year":"1988","unstructured":"Field LJ. Atrial natriuretic factor-SV40 T antigen transgenes produce tumors and cardiac arrhythmias in mice. Science. 1988;239(4843):1029\u201333.","journal-title":"Science."},{"issue":"8","key":"1206_CR12","doi-asserted-by":"publisher","first-page":"2648","DOI":"10.1073\/pnas.85.8.2648","volume":"85","author":"RR Behringer","year":"1988","unstructured":"Behringer RR, Peschon JJ, Messing A, Gartside CL, Hauschka SD, Palmiter RD, et al. Heart and bone tumors in transgenic mice. Proc Natl Acad Sci U S A. 1988;85(8):2648\u201352.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6 Pt 2","key":"1206_CR13","first-page":"H1867","volume":"262","author":"EB Katz","year":"1992","unstructured":"Katz EB, Steinhelper ME, Delcarpio JB, Daud AI, Claycomb WC, Field LJ. Cardiomyocyte proliferation in mice expressing alpha-cardiac myosin heavy chain-SV40 T-antigen transgenes. Am J Phys. 1992;262(6 Pt 2):H1867\u201376.","journal-title":"Am J Phys"},{"issue":"1","key":"1206_CR14","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1161\/01.RES.0000152326.91223.4F","volume":"96","author":"KB Pasumarthi","year":"2005","unstructured":"Pasumarthi KB, Nakajima H, Nakajima HO, Soonpaa MH, Field LJ. Targeted expression of cyclin D2 results in cardiomyocyte DNA synthesis and infarct regression in transgenic mice. Circ Res. 2005;96(1):110\u20138.","journal-title":"Circ Res"},{"issue":"1","key":"1206_CR15","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1093\/cvr\/cvm101","volume":"78","author":"RJ Hassink","year":"2008","unstructured":"Hassink RJ, Pasumarthi KB, Nakajima H, Rubart M, Soonpaa MH, de la Riviere AB, et al. Cardiomyocyte cell cycle activation improves cardiac function after myocardial infarction. Cardiovasc Res. 2008;78(1):18\u201325.","journal-title":"Cardiovasc Res"},{"issue":"1","key":"1206_CR16","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1161\/01.RES.0000197783.70106.4a","volume":"98","author":"H Nakajima","year":"2006","unstructured":"Nakajima H, Nakajima HO, Dembowsky K, Pasumarthi KB, Field LJ. Cardiomyocyte cell cycle activation ameliorates fibrosis in the atrium. Circ Res. 2006;98(1):141\u20138.","journal-title":"Circ Res"},{"issue":"5","key":"1206_CR17","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1161\/01.RES.86.5.571","volume":"86","author":"H Nakajima","year":"2000","unstructured":"Nakajima H, Nakajima HO, Salcher O, Dittie AS, Dembowsky K, Jing S, et al. Atrial but not ventricular fibrosis in mice expressing a mutant transforming growth factor-beta(1) transgene in the heart. Circ Res. 2000;86(5):571\u20139.","journal-title":"Circ Res"},{"issue":"12","key":"1206_CR18","doi-asserted-by":"publisher","first-page":"4285","DOI":"10.1172\/JCI81870","volume":"127","author":"K Toischer","year":"2017","unstructured":". Toischer K, Zhu W, Hunlich M, Mohamed BA, Khadjeh S, Reuter SP, et al. Cardiomyocyte proliferation prevents failure in pressure overload but not volume overload. J Clin Invest. 2017;127(12):4285\u201396. \n                      https:\/\/doi.org\/10.1172\/JCI81870\n                      \n                     Findings from this study suggest that the presence of cardiomyocyte cell cycle activity can block the onset of heart failure resulting from chronic increases in cardiac afterload.","journal-title":"J Clin Invest"},{"issue":"5","key":"1206_CR19","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1093\/cvr\/cvy273","volume":"115","author":"W Zhu","year":"2019","unstructured":". Zhu W, Reuter S, Field LJ. Targeted expression of cyclin D2 ameliorates late stage anthracycline cardiotoxicity. Cardiovasc Res. 2019;115(5):960\u20135. \n                      https:\/\/doi.org\/10.1093\/cvr\/cvy273\n                      \n                     Findings from this study demonstrate that the presence of cardiomyocyte cell cycle activity can reverse heart failure in a chronic juvenile doxorubicin cardiotoxicity model.","journal-title":"Cardiovasc Res"},{"issue":"5","key":"1206_CR20","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1203\/PDR.0b013e318184d732","volume":"64","author":"W Zhu","year":"2008","unstructured":"Zhu W, Shou W, Payne RM, Caldwell R, Field LJ. A mouse model for juvenile doxorubicin-induced cardiac dysfunction. Pediatr Res. 2008;64(5):488\u201394.","journal-title":"Pediatr Res"}],"container-title":["Current Cardiology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-019-1206-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11886-019-1206-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-019-1206-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T23:25:08Z","timestamp":1600125908000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11886-019-1206-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,16]]},"references-count":20,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["1206"],"URL":"https:\/\/doi.org\/10.1007\/s11886-019-1206-9","relation":{},"ISSN":["1523-3782","1534-3170"],"issn-type":[{"value":"1523-3782","type":"print"},{"value":"1534-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,16]]},"assertion":[{"value":"16 September 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Arash Eghbali, Austin Dukes, Karl Toischer, and Loren J. Field declare that they have no conflict of interest.Gerd Hasenfuss reports personal fees from Corvia, Servier, Impulse Dynamics, Novartis, AstraZeneca, Vifor Pharma, Berlin Chemie, and Springer.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All reported studies\/experiments with human or animal subjects performed by the authors have been previously published and complied with all applicable ethical standards (including the Helsinki Declaration and its amendments, institutional\/national research committee standards, and international\/national\/institutional guidelines).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"131"}}